C OSBORNE to Risk
This is a "connection" page, showing publications C OSBORNE has written about Risk.
Connection Strength
0.014
-
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study. J Clin Oncol. 1998 Nov; 16(11):3486-92.
Score: 0.008
-
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer. J Natl Cancer Inst. 1995 Aug 16; 87(16):1254-6.
Score: 0.006